The TRAIL selectively promotes apoptosis by interacting with death receptors TRAIL-R1 (or DR4) and TRAIL-R2 (or DR5), which are excessively expressed in different types of cancer cells.24 In addition, low or no expression of decoy receptors should be observed on the targeted cell. This evidence concerns the gene TNFRSF10B and cancer.